OBJECTIVE: To use near infrared spectroscopy (NIRS) to evaluate the timing of onset and duration of cerebral hyperemia during diabetic ketoacidosis (DKA) treatment in children, and to investigate the relationship of cerebral hyperemia to intravenous fluid treatment. STUDY DESIGN: We randomized children aged 8-18 years with DKA to either more rapid or slower intravenous fluid treatment (19 total DKA episodes). NIRS was used to measure rSo2 during DKA treatment. NIRS monitoring began as soon as informed consent was obtained and continued until the patient was transferred out of the critical care unit. RESULTS:rSo2 values above the normal range (>80%) were detected in 17 of 19 DKA episodes (mean rSo2 during initial 8 hours of DKA treatment: 86% ± 7%, range 65%-95%). Elevated rSo2 values were detected as early as the second hour of DKA treatment and persisted for as long as 27 hours. Hourly mean rSo2 levels during treatment did not differ significantly by fluid treatment group. CONCLUSIONS: During DKA treatment, children have elevated rSo2 values consistent with cerebral hyperemia. Hyperemia occurs as early as the second hour of DKA treatment and may persist for ≥ 27 hours. Cerebral rSo2 levels during treatment did not differ significantly in patients treated with slower versus more rapid intravenous rehydration.
RCT Entities:
OBJECTIVE: To use near infrared spectroscopy (NIRS) to evaluate the timing of onset and duration of cerebral hyperemia during diabetic ketoacidosis (DKA) treatment in children, and to investigate the relationship of cerebral hyperemia to intravenous fluid treatment. STUDY DESIGN: We randomized children aged 8-18 years with DKA to either more rapid or slower intravenous fluid treatment (19 total DKA episodes). NIRS was used to measure rSo2 during DKA treatment. NIRS monitoring began as soon as informed consent was obtained and continued until the patient was transferred out of the critical care unit. RESULTS:rSo2 values above the normal range (>80%) were detected in 17 of 19 DKA episodes (mean rSo2 during initial 8 hours of DKA treatment: 86% ± 7%, range 65%-95%). Elevated rSo2 values were detected as early as the second hour of DKA treatment and persisted for as long as 27 hours. Hourly mean rSo2 levels during treatment did not differ significantly by fluid treatment group. CONCLUSIONS: During DKA treatment, children have elevated rSo2 values consistent with cerebral hyperemia. Hyperemia occurs as early as the second hour of DKA treatment and may persist for ≥ 27 hours. Cerebral rSo2 levels during treatment did not differ significantly in patients treated with slower versus more rapid intravenous rehydration.
Authors: Nicole S Glaser; Sandra L Wootton-Gorges; Michael H Buonocore; Daniel J Tancredi; James P Marcin; Ryan Caltagirone; Yvonne Lee; Christopher Murphy; Nathan Kuppermann Journal: Pediatrics Date: 2012-12-10 Impact factor: 7.124
Authors: Philipp Taussky; Brandon O'Neal; Wilson P Daugherty; Sothear Luke; Dallas Thorpe; Robert A Pooley; Clay Evans; Ricardo A Hanel; William D Freeman Journal: Neurosurg Focus Date: 2012-02 Impact factor: 4.047
Authors: Nicole S Glaser; Sandra L Wootton-Gorges; James P Marcin; Michael H Buonocore; Joseph Dicarlo; E Kirk Neely; Patrick Barnes; Jenny Bottomly; Nathan Kuppermann Journal: J Pediatr Date: 2004-08 Impact factor: 4.406
Authors: Nicole S Glaser; Sandra L Wootton-Gorges; Isaac Kim; Daniel J Tancredi; James P Marcin; Andrew Muir; Nathan Kuppermann Journal: J Pediatr Date: 2016-10-13 Impact factor: 4.406
Authors: Andrew DePiero; Nathan Kuppermann; Kathleen M Brown; Jeff E Schunk; Julie K McManemy; Arleta Rewers; Michael J Stoner; Leah Tzimenatos; Aris Garro; Sage R Myers; Kimberly S Quayle; Jennifer L Trainor; Maria Y Kwok; Lise E Nigrovic; Cody S Olsen; T Charles Casper; Simona Ghetti; Nicole S Glaser Journal: J Pediatr Date: 2020-05-06 Impact factor: 4.406
Authors: Jennifer C Laws; Lori C Jordan; Lindsay M Pagano; John C Wellons; Michael S Wolf Journal: Pediatr Neurol Date: 2022-02-02 Impact factor: 3.372
Authors: Nathan Kuppermann; Simona Ghetti; Jeff E Schunk; Michael J Stoner; Arleta Rewers; Julie K McManemy; Sage R Myers; Lise E Nigrovic; Aris Garro; Kathleen M Brown; Kimberly S Quayle; Jennifer L Trainor; Leah Tzimenatos; Jonathan E Bennett; Andrew D DePiero; Maria Y Kwok; Clinton S Perry; Cody S Olsen; T Charles Casper; J Michael Dean; Nicole S Glaser Journal: N Engl J Med Date: 2018-06-14 Impact factor: 91.245
Authors: Kelly R Bergmann; Donna M Milner; Constantinos Voulgaropoulos; Gretchen J Cutler; Anupam B Kharbanda Journal: West J Emerg Med Date: 2016-07-25